MedTrace Logo

A Study of Cerebral Perfusion With tDCS in Chronic Hypoperfusion

NCT06477107 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2026-01-20

No results posted yet for this study

Summary

This study is being done to examine whether transcranial direct current stimulation (tDCS) will increase cerebral blood flow which may provide a clinical benefit such as improving cognitive impairment.

Conditions

  • Moyamoya Syndrome
  • Moyamoya Disease
  • Atheroscleroses, Cerebral

Interventions

DEVICE

Soterix® 4x1HD-TDCS

Is intended for inducing cortical neuromodulation for research and treatment purposes.

DEVICE

Soterix® 1x1 tDCS

At-home remotely supervised transcranial direct current stimulation (tDCS) at an intensity of 2 mA for 20 minutes per session, with slow ramp-up and automatic turn off once it reaches the maximal intensity.

BEHAVIORAL

Cognitive training program

Computerized cognitive therapy for 45 minutes per day that starts at the same time with stimulation

Sponsors & Collaborators

Principal Investigators

  • Zafer Keser · Mayo Clinic

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-10-24
Primary Completion
2026-06-30
Completion
2026-06-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06477107 on ClinicalTrials.gov